Patents by Inventor Gerhard LEINENGA

Gerhard LEINENGA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES
    Publication number: 20230030950
    Abstract: The present invention relates to antigen binding sites, compositions and uses thereof in the treatment of conditions associated with pathogenic proteins. In one example the condition is Alzheimer's disease.
    Type: Application
    Filed: December 3, 2020
    Publication date: February 2, 2023
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Juergen GOETZ, Gerhard LEINENGA
  • Neurodegenerative disease treatment
    Patent number: 11369809
    Abstract: The present invention is directed to methods for treating neurodegenerative diseases and/or improving cognitive function, in particular those associated with protein oligomers, aggregates or deposits, using acoustic energy, such as ultrasound. An 5 example of such a neurodegenerative disease is Alzheimer's disease. The present invention provides a method of improving cognitive function and/or memory in an individual with impaired memory and/or executive function, the method including the steps of identifying a region of the brain of the individual to be treated with acoustic energy, applying a clinically safe level of acoustic energy to the region, thereby 10 saturating or substantially saturating the region with acoustic energy, thereby improving memory in the individual.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 28, 2022
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Juergen Goetz, Gerhard Leinenga
  • METHODS AND COMPOSITIONS FOR TREATING TAUOPATHIES
    Publication number: 20210347869
    Abstract: The invention relates to tau, to antibodies and related fragments thereof for binding to tau, to production of said antibodies and fragments and to use of said antibodies and fragments for detection and therapy of various conditions, including tauopathies. The invention also relates to compositions comprising tau antibodies for binding to tau and their use in combination with acoustic energy.
    Type: Application
    Filed: October 17, 2018
    Publication date: November 11, 2021
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Juergen GOETZ, Rebecca NISBET, Phillip JANOWICZ, Gerhard LEINENGA
  • NEURODEGENERATIVE DISEASE TREATMENT
    Publication number: 20180214716
    Abstract: The present invention is directed to methods for treating neurodegenerative diseases and/or improving cognitive function, in particular those associated with protein oligomers, aggregates or deposits, using acoustic energy, such as ultrasound. An 5 example of such a neurodegenerative disease is Alzheimer's disease. The present invention provides a method of improving cognitive function and/or memory in an individual with impaired memory and/or executive function, the method including the steps of identifying a region of the brain of the individual to be treated with acoustic energy, applying a clinically safe level of acoustic energy to the region, thereby 10 saturating or substantially saturating the region with acoustic energy, thereby improving memory in the individual.
    Type: Application
    Filed: June 19, 2015
    Publication date: August 2, 2018
    Inventors: Juergen GOETZ, Gerhard LEINENGA